Partnership Opportunities

Partner with the Only Industry-Dedicated Kinase Inhibitor Meeting
to Maximize your Influence

The 3rd Kinase Targeted Drug Discovery Summit is a transformative forum bringing together 70+ kinase experts from the pharmaceutical, biotechnology, and academic sectors. From target identification and lead optimization to assay development, join an engaged audience dedicated to preclinical kinase success.

Our industry’s decision-makers need your latest platforms, tools, and technologies to maximize their discovery capabilities to achieve the next generation of kinase therapies.

DISCOVER PARTNERSHIP OPPORTUNITIES

Why Partner?

This is your unique opportunity to kickstart 2025 as a leading service provider.
With a unified goal to improve previous generations of kinase therapeutics, you can contribute to a modality-agnostic solution for disease indications involving dysfunctional kinases across oncology, immunology, dermatology, neurodegeneration and more.

Don’t miss your chance to:
element 1

Enable highly sensitive assays that can screen against a comprehensive set of kinases

elements 3

Display advanced phospho-proteomic profiling platforms that can identify critical phosphorylation sites

elements 4

Spotlight computational drug design tools that can enhance predictive models of complex kinase interactions

elements 5

Present ground-breaking cryo-EM technologies that can deliver high-resolution structures of transient domains

GET IN TOUCH

Address Critical Industry Needs

Our Kinase Drug Developers & Researchers Need Your Help With:

2nd Next Generation Kinase Inhibitors Summit logo FINAL ICON
2nd Next Generation Kinase Inhibitors Summit logo FINAL ICON
2nd Next Generation Kinase Inhibitors Summit logo FINAL ICON
2nd Next Generation Kinase Inhibitors Summit logo FINAL ICON

Highly sensitive kinase assays

Advanced phospho-proteomic profiling platforms

Computational and AI drug design tools

Ground-breaking cryo-EM technologies